Cannabidiol In Experimental Epilepsy: A Review of Preclinical Rat Models

作者
Aphroz Ansari*1, Pushpa Prasad Gupta1, Ramsheela2, Masoom Rahbar3
出处
期刊:International Journal of Medical and Pharmaceutical Sciences
标识
DOI:10.5281/zenodo.22015344
摘要

Epilepsy is a chronic neurological disorder characterized by recurrent unprovoked seizures and is frequently accompanied by cognitive, behavioral, and psychiatric comorbidities. Despite the availability of numerous antiseizure medications, a substantial proportion of patients remain inadequately controlled, creating a need for therapies with novel mechanisms. Cannabidiol (CBD), a non-intoxicating phytocannabinoid derived from Cannabis sativa, has emerged as a promising antiseizure compound and has subsequently gained regulatory approval for selected developmental and epileptic encephalopathies. This review focuses specifically on preclinical evidence from rat models of epilepsy, emphasizing seizure control, neuroprotection, neuroinflammation, antiepileptogenic effects, pharmacokinetics, and potential mechanisms of action. Studies using pentylenetetrazol (PTZ), pilocarpine, lithium-pilocarpine, kainic acid, audiogenic kindling, and other experimental paradigms demonstrate that CBD can reduce seizure severity, delay seizure onset, decrease seizure burden, and in some models suppress the development or expression of chronic epileptic activity. In rat models of temporal lobe epilepsy, CBD has additionally been associated with reduced neuronal degeneration, modulation of inflammatory cytokines and microglial polarization, changes in PPARγ signaling, and alterations in gut microbiota and metabolomic profiles. Importantly, effects vary with dose, route, treatment timing, model, age, and disease stage. Evidence for genuine antiepileptogenesis remains promising but less established than evidence for acute antiseizure activity. Translation is further complicated by differences in CBD exposure, formulation, metabolism, and pharmacodynamic responses between rodents and humans. Overall, rat studies provide strong mechanistic support for CBD as an antiseizure and potentially neuroprotective agent, but standardized chronic epilepsy protocols, exposure–response studies, sex-balanced designs, rigorous pharmacokinetic–pharmacodynamic characterization, and clinically relevant endpoints are needed to establish its translational value.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
夜末鲤完成签到,获得积分10
1秒前
真的很哇塞完成签到,获得积分10
2秒前
2秒前
美鹅完成签到 ,获得积分10
3秒前
SuYuo完成签到,获得积分10
3秒前
3秒前
ghn123456789完成签到,获得积分0
4秒前
上好佳完成签到,获得积分10
4秒前
小成完成签到 ,获得积分10
4秒前
Nole的应助被shao采纳,获得10
4秒前
木仓完成签到,获得积分10
4秒前
传奇3的应助被cc采纳,获得10
4秒前
4秒前
Ava的应助被小胖子采纳,获得10
4秒前
科目三的应助被清修采纳,获得10
5秒前
梓越完成签到 ,获得积分10
6秒前
Cytheria完成签到,获得积分10
6秒前
沉默天宇完成签到,获得积分10
6秒前
张乐完成签到,获得积分10
7秒前
ncc完成签到,获得积分10
7秒前
曾经的千柔完成签到,获得积分10
8秒前
伤訫凉皮完成签到 ,获得积分10
8秒前
武子阳完成签到 ,获得积分10
9秒前
上好佳发布了新的文献求助10
9秒前
研友_842M4n完成签到,获得积分10
10秒前
小困包发布了新的文献求助10
10秒前
wcuzhl完成签到,获得积分10
11秒前
樊兮完成签到,获得积分10
11秒前
relycoris完成签到,获得积分10
11秒前
无名小卒完成签到,获得积分10
11秒前
lll完成签到 ,获得积分10
11秒前
Joaquin完成签到,获得积分10
12秒前
12秒前
撒大大完成签到,获得积分10
13秒前
华老五完成签到,获得积分10
13秒前
ll的应助被第二人生采纳,获得10
14秒前
生盐柠茶完成签到 ,获得积分10
14秒前
Starain完成签到,获得积分10
15秒前
15秒前
kaiz完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166653
求助须知:如何正确求助?哪些是违规求助? 9559595
关于积分的说明 21751026
捐赠科研通 7757480
什么是DOI,文献DOI怎么找? 3429172
关于科研通互助平台的介绍 2553536
邀请新用户注册赠送积分活动 2473931